{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:42:32Z","timestamp":1790170952704,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Appl Genetics"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s13353-020-00580-6","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T17:02:58Z","timestamp":1599843778000},"page":"547-558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Genetic modifiers and phenotypic variability in neuromuscular disorders"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8731-0540","authenticated-orcid":false,"given":"Magdalena","family":"Mroczek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriela","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"580_CR1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/gepi.21699","volume":"37","author":"IJ Barnett","year":"2013","unstructured":"Barnett IJ, Lee S, Lin X (2013) Detecting rare variant effects using extreme phenotype sampling in sequencing association studies. Genet Epidemiol 37:142\u2013151","journal-title":"Genet Epidemiol"},{"key":"580_CR2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature22038","volume":"544","author":"LA Becker","year":"2017","unstructured":"Becker LA, Huang B, Bieri G, Ma R, Knowles DA, Jafar-Nejad P, Messing J, Kim HJ, Soriano A, Auburger G, Pulst SM, Taylor JP, Rigo F, Gitler AD (2017) Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature 544:367\u2013371","journal-title":"Nature"},{"key":"580_CR3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ajhg.2016.08.023","volume":"99","author":"L Bello","year":"2016","unstructured":"Bello L, Flanigan KM, Weiss RB, Spitali P, Aartsma-Rus A, Muntoni F, Zaharieva I, Ferlini A, Mercuri E, Tuffery-Giraud S, Claustres M, Straub V, Lochm\u00fcller H, Barp A, Vianello S, Pegoraro E, Punetha J, Gordish-Dressman H, Giri M, McDonald CM, Hoffman EP (2016) Association study of exon variants in the NF-\u03baB and TGF\u03b2 pathways identifies CD40 as a modifier of Duchenne muscular dystrophy. Am J Hum Genet 99:1163\u20131171","journal-title":"Am J Hum Genet"},{"key":"580_CR4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13023-019-1291-2","volume":"15","author":"JA Bevilacqua","year":"2020","unstructured":"Bevilacqua JA, Guecaimburu Ehuletche MDR, Perna A, Dubrovsky A, Franca MC Jr, Vargas S, Hegde M, Claeys KG, Straub V, Daba N, Faria R, Periquet M, Sparks S, Thibault N, Araujo R (2020) The Latin American experience with a next generation sequencing genetic panel for recessive limb-girdle muscular weakness and Pompe disease. Orphanet J Rare Dis 15:11","journal-title":"Orphanet J Rare Dis"},{"key":"580_CR5","volume-title":"GeneReviews(\u00ae)","author":"TD Bird","year":"1993","unstructured":"Bird TD (1993) Charcot-Marie-Tooth (CMT) hereditary neuropathy overview. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A (eds) GeneReviews(\u00ae). University of Washington, Seattle"},{"issue":"Pt 5","key":"580_CR6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/brain\/120.5.813","volume":"120","author":"N Birouk","year":"1997","unstructured":"Birouk N, Gouider R, Le Guern E, Gugenheim M, Tardieu S, Maisonobe T, Le Forestier N, Agid Y, Brice A, Bouche P (1997) Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 120(Pt 5):813\u2013823","journal-title":"Brain"},{"key":"580_CR7","doi-asserted-by":"crossref","first-page":"146459","DOI":"10.1016\/j.brainres.2019.146459","volume":"1726","author":"DM Bis-Brewer","year":"2020","unstructured":"Bis-Brewer DM, Fazal S, Z\u00fcchner S (2020) Genetic modifiers and non-Mendelian aspects of CMT. Brain Res 1726:146459","journal-title":"Brain Res"},{"key":"580_CR8","doi-asserted-by":"crossref","first-page":"2906.e1","DOI":"10.1016\/j.neurobiolaging.2015.06.013","volume":"36","author":"G Borghero","year":"2015","unstructured":"Borghero G, Pugliatti M, Marrosu F, Marrosu MG, Murru MR, Floris G, Cannas A, Parish LD, Cau TB, Loi D, Ticca A, Traccis S, Manera U, Canosa A, Moglia C, Calvo A, Barberis M, Brunetti M, Renton AE, Nalls MA, Traynor BJ, Restagno G, Chi\u00f2 A (2015) ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry. Neurobiol Aging 36:2906.e1\u20132906.e5","journal-title":"Neurobiol Aging"},{"key":"580_CR9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2044-5040-1-19","volume":"1","author":"TN Burks","year":"2011","unstructured":"Burks TN, Cohn RD (2011) Role of TGF-\u03b2 signaling in inherited and acquired myopathies. Skelet Muscle 1:19","journal-title":"Skelet Muscle"},{"key":"580_CR10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s12864-017-3964-3","volume":"18","author":"JM Butler","year":"2017","unstructured":"Butler JM, Hall N, Narendran N, Yang YC, Paraoan L (2017) Identification of candidate protective variants for common diseases and evaluation of their protective potential. BMC Genomics 18:575","journal-title":"BMC Genomics"},{"key":"580_CR11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1750-1326-8-28","volume":"8","author":"S Chen","year":"2013","unstructured":"Chen S, Sayana P, Zhang X, Le W (2013) Genetics of amyotrophic lateral sclerosis: an update. Mol Neurodegener 8:28","journal-title":"Mol Neurodegener"},{"key":"580_CR12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1212\/WNL.0000000000001159","volume":"84","author":"A Chi\u00f2","year":"2015","unstructured":"Chi\u00f2 A, Calvo A, Moglia C, Canosa A, Brunetti M, Barberis M, Restagno G, Conte A, Bisogni G, Marangi G, Moncada A, Lattante S, Zollino M, Sabatelli M, Bagarotti A, Corrado L, Mora G, Bersano E, Mazzini L, D\u2019Alfonso S (2015) ATXN2 polyQ intermediate repeats are a modifier of ALS survival. Neurology 84:251\u2013258","journal-title":"Neurology"},{"key":"580_CR13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41431-018-0272-6","volume":"27","author":"D Curtis","year":"2019","unstructured":"Curtis D (2019) A weighted burden test using logistic regression for integrated analysis of sequence variants, copy number variants and polygenic risk score. Eur J Hum Genet 27:114\u2013124","journal-title":"Eur J Hum Genet"},{"key":"580_CR14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/hmg\/9.2.217","volume":"9","author":"DB Davis","year":"2000","unstructured":"Davis DB, Delmonte AJ, Ly CT, McNally EM (2000) Myoferlin, a candidate gene and potential modifier of muscular dystrophy. Hum Mol Genet 9:217\u2013226","journal-title":"Hum Mol Genet"},{"key":"580_CR15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.ejhg.5200888","volume":"10","author":"F de Paula","year":"2002","unstructured":"de Paula F, Vainzof M, Passos-Bueno MR, de C\u00e1ssia M Pavanello R, Matioli SR, Anderson LVB, Nigro V, Zatz M (2002) Clinical variability in calpainopathy: what makes the difference? Eur J Hum Genet 10:825\u2013832","journal-title":"Eur J Hum Genet"},{"key":"580_CR16","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2174\/138161212799315920","volume":"18","author":"R Dorfman","year":"2012","unstructured":"Dorfman R (2012) Modifier gene studies to identify new therapeutic targets in cystic fibrosis. Curr Pharm Des 18:674\u2013682","journal-title":"Curr Pharm Des"},{"key":"580_CR17","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","volume":"466","author":"AC Elden","year":"2010","unstructured":"Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, Padmanabhan A, Clay-Falcone D, McCluskey L, Elman L, Juhr D, Gruber PJ, R\u00fcb U, Auburger G, Trojanowski JQ, Lee VM, Van Deerlin VM, Bonini NM, Gitler AD (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466:1069\u20131075","journal-title":"Nature"},{"key":"580_CR18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41467-018-07931-2","volume":"10","author":"G Eraslan","year":"2019","unstructured":"Eraslan G, Simon LM, Mircea M, Mueller NS, Theis FJ (2019) Single-cell RNA-seq denoising using a deep count autoencoder. Nat Commun 10:390","journal-title":"Nat Commun"},{"key":"580_CR19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40246-018-0167-1","volume":"12","author":"JP Fichna","year":"2018","unstructured":"Fichna JP, Macias A, Piechota M, Korosty\u0144ski M, Potulska-Chromik A, Redowicz MJ, Zekanowski C (2018) Whole-exome sequencing identifies novel pathogenic mutations and putative phenotype-influencing variants in Polish limb-girdle muscular dystrophy patients. Hum Genomics 12:34","journal-title":"Hum Genomics"},{"key":"580_CR20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.23819","volume":"73","author":"KM Flanigan","year":"2013","unstructured":"Flanigan KM, Ceco E, Lamar KM, Kaminoh Y, Dunn DM, Mendell JR, King WM, Pestronk A, Florence JM, Mathews KD, Finkel RS, Swoboda KJ, Gappmaier E, Howard MT, Day JW, McDonald C, McNally EM, Weiss RB (2013) LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy. Ann Neurol 73:481\u2013488","journal-title":"Ann Neurol"},{"key":"580_CR21","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/jamaneurol.2016.1114","volume":"73","author":"I Fogh","year":"2016","unstructured":"Fogh I, Lin K, Tiloca C, Rooney J, Gellera C, Diekstra FP, Ratti A, Shatunov A, van Es MA, Proitsi P, Jones A, Sproviero W, Chi\u00f2 A, McLaughlin RL, Sorar\u00f9 G, Corrado L, Stahl D, Del Bo R, Cereda C, Castellotti B, Glass JD, Newhouse S, Dobson R, Smith BN, Topp S, van Rheenen W, Meininger V, Melki J, Morrison KE, Shaw PJ, Leigh PN, Andersen PM, Comi GP, Ticozzi N, Mazzini L, D\u2019Alfonso S, Traynor BJ, Van Damme P, Robberecht W, Brown RH, Landers JE, Hardiman O, Lewis CM, van den Berg LH, Shaw CE, Veldink JH, Silani V, Al-Chalabi A, Powell J (2016) Association of a locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis. JAMA Neurol 73:812\u2013820","journal-title":"JAMA Neurol"},{"key":"580_CR22","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1001\/jamaneurol.2015.2274","volume":"72","author":"R Ghaoui","year":"2015","unstructured":"Ghaoui R, Cooper ST, Lek M, Jones K, Corbett A, Reddel SW, Needham M, Liang C, Waddell LB, Nicholson G, O\u2019Grady G, Kaur S, Ong R, Davis M, Sue CM, Laing NG, North KN, MacArthur DG, Clarke NF (2015) Use of whole-exome sequencing for diagnosis of limb-girdle muscular dystrophy: outcomes and lessons learned. JAMA Neurol 72:1424\u20131432","journal-title":"JAMA Neurol"},{"key":"580_CR23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.aat5056","volume":"364","author":"CA Gifford","year":"2019","unstructured":"Gifford CA, Ranade SS, Samarakoon R, Salunga HT, de Soysa TY, Huang Y, Zhou P, Elfenbein A, Wyman SK, Bui YK, Cordes Metzler KR, Ursell P, Ivey KN, Srivastava D (2019) Oligogenic inheritance of a human heart disease involving a genetic modifier. Science 364:865\u2013870","journal-title":"Science"},{"key":"580_CR24","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.celrep.2015.07.023","volume":"12","author":"C Gonzaga-Jauregui","year":"2015","unstructured":"Gonzaga-Jauregui C, Harel T, Gambin T, Kousi M, Griffin LB, Francescatto L, Ozes B, Karaca E, Jhangiani SN, Bainbridge MN, Lawson KS, Pehlivan D, Okamoto Y, Withers M, Mancias P, Slavotinek A, Reitnauer PJ, Goksungur MT, Shy M, Crawford TO, Koenig M, Willer J, Flores BN, Pediaditrakis I, Us O, Wiszniewski W, Parman Y, Antonellis A, Muzny DM, Katsanis N, Battaloglu E, Boerwinkle E, Gibbs RA, Lupski JR (2015) Exome sequence analysis suggests that genetic burden contributes to phenotypic variability and complex neuropathy. Cell Rep 12:1169\u20131183","journal-title":"Cell Rep"},{"key":"580_CR25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02983018","volume":"41","author":"J Haldane","year":"1941","unstructured":"Haldane J (1941) The relative importance of principal and modifying genes in determining some human diseases. J Genet 41:149\u2013157","journal-title":"J Genet"},{"key":"580_CR26","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nature15510","volume":"526","author":"W He","year":"2015","unstructured":"He W, Bai G, Zhou H, Wei N, White NM, Lauer J, Liu H, Shi Y, Dumitru CD, Lettieri K, Shubayev V, Jordanova A, Guergueltcheva V, Griffin PR, Burgess RW, Pfaff SL, Yang XL (2015) CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase. Nature 526:710\u2013714","journal-title":"Nature"},{"key":"580_CR27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mus.25953","volume":"57","author":"RM Hightower","year":"2018","unstructured":"Hightower RM, Alexander MS (2018) Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophies. Muscle Nerve 57:6\u201315","journal-title":"Muscle Nerve"},{"key":"580_CR28","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/CIRCGENETICS.113.000042","volume":"6","author":"GS Huggins","year":"2013","unstructured":"Huggins GS, Papandonatos GD, Erar B, Belalcazar LM, Brautbar A, Ballantyne C, Kitabchi AE, Wagenknecht LE, Knowler WC, Pownall HJ, Wing RR, Peter I, McCaffery JM (2013) Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus?: the Action for Health in Diabetes (Look AHEAD) study. Circ Cardiovasc Genet 6:391\u2013399","journal-title":"Circ Cardiovasc Genet"},{"key":"580_CR29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.brainres.2006.02.021","volume":"1091","author":"KR Johnson","year":"2006","unstructured":"Johnson KR, Zheng QY, Noben-Trauth K (2006) Strain background effects and genetic modifiers of hearing in mice. Brain Res 1091:79\u201388","journal-title":"Brain Res"},{"key":"580_CR30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg.2018.4","volume":"19","author":"KJ Karczewski","year":"2018","unstructured":"Karczewski KJ, Snyder MP (2018) Integrative omics for health and disease. Nat Rev Genet 19:299\u2013310","journal-title":"Nat Rev Genet"},{"key":"580_CR31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13059-016-1107-9","volume":"17","author":"N Katsanis","year":"2016","unstructured":"Katsanis N (2016) The continuum of causality in human genetic disorders. Genome Biol 17:233","journal-title":"Genome Biol"},{"key":"580_CR32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.gde.2010.12.007","volume":"21","author":"JA Kearney","year":"2011","unstructured":"Kearney JA (2011) Genetic modifiers of neurological disease. Curr Opin Genet Dev 21:349\u2013353","journal-title":"Curr Opin Genet Dev"},{"key":"580_CR33","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1038\/mtna.2014.7","volume":"3","author":"DU Kemaladewi","year":"2014","unstructured":"Kemaladewi DU, Pasteuning S, van der Meulen JW, van Heiningen SH, van Ommen GJ, Ten Dijke P, Aartsma-Rus A, t Hoen PA, Hoogaars WM (2014) Targeting TGF-\u03b2 signaling by antisense oligonucleotide-mediated knockdown of TGF-\u03b2 type I receptor. Mol Ther Nucleic Acids 3:e156","journal-title":"Mol Ther Nucleic Acids"},{"key":"580_CR34","doi-asserted-by":"publisher","unstructured":"Kousi M, Katsanis N (2015) Genetic modifiers and oligogenic inheritance. Cold Spring Harb Perspect Med 5(6):a017145. https:\/\/doi.org\/10.1101\/cshperspect.a017145","DOI":"10.1101\/cshperspect.a017145"},{"key":"580_CR35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41588-018-0070-7","volume":"50","author":"NJ Kramer","year":"2018","unstructured":"Kramer NJ, Haney MS, Morgens DW, Jovi\u010di\u0107 A, Couthouis J, Li A, Ousey J, Ma R, Bieri G, Tsui CK, Shi Y, Hertz NT, Tessier-Lavigne M, Ichida JK, Bassik MC, Gitler AD (2018) CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity. Nat Genet 50:603\u2013612","journal-title":"Nat Genet"},{"key":"580_CR36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JND-140023","volume":"1","author":"KM Lamar","year":"2014","unstructured":"Lamar KM, McNally EM (2014) Genetic modifiers for neuromuscular diseases. J Neuromuscul Dis 1:3\u201313","journal-title":"J Neuromuscul Dis"},{"key":"580_CR37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.devcel.2011.06.007","volume":"21","author":"ND Lawson","year":"2011","unstructured":"Lawson ND, Wolfe SA (2011) Forward and reverse genetic approaches for the analysis of vertebrate development in the zebrafish. Dev Cell 21:48\u201364","journal-title":"Dev Cell"},{"key":"580_CR38","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ng.2454","volume":"44","author":"RJ Lemmers","year":"2012","unstructured":"Lemmers RJ, Tawil R, Petek LM, Balog J, Block GJ, Santen GW, Amell AM, van der Vliet PJ, Almomani R, Straasheijm KR, Krom YD, Klooster R, Sun Y, den Dunnen JT, Helmer Q, Donlin-Smith CM, Padberg GW, van Engelen BG, de Greef JC, Aartsma-Rus AM, Frants RR, de Visser M, Desnuelle C, Sacconi S, Filippova GN, Bakker B, Bamshad MJ, Tapscott SJ, Miller DG, van der Maarel SM (2012) Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet 44:1370\u20131374","journal-title":"Nat Genet"},{"key":"580_CR39","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s12035-012-8370-x","volume":"47","author":"J Li","year":"2013","unstructured":"Li J, Parker B, Martyn C, Natarajan C, Guo J (2013) The PMP22 gene and its related diseases. Mol Neurobiol 47:673\u2013698","journal-title":"Mol Neurobiol"},{"key":"580_CR40","doi-asserted-by":"publisher","unstructured":"Li S, Datta S, Brabbit E, Love Z, Woytowicz V, Flattery K, Capri J, Yao K, Wu S, Imboden M, Upadhyay A, Arumugham R, Thoreson WB, DeAngelis MM, Haider NB (2020) Nr2e3 is a genetic modifier that rescues retinal degeneration and promotes homeostasis in multiple models of retinitis pigmentosa. Gene Ther. https:\/\/doi.org\/10.1038\/s41434-020-0134-z","DOI":"10.1038\/s41434-020-0134-z"},{"key":"580_CR41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrg3920","volume":"16","author":"MW Libbrecht","year":"2015","unstructured":"Libbrecht MW, Noble WS (2015) Machine learning applications in genetics and genomics. Nat Rev Genet 16:321\u2013332","journal-title":"Nat Rev Genet"},{"key":"580_CR42","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s00415-005-0797-9","volume":"252","author":"W Marques Jr","year":"2005","unstructured":"Marques W Jr, Freitas MR, Nascimento OJ, Oliveira AB, Calia L, Melo A, Lucena R, Rocha V, Barreira AA (2005) 17p duplicated Charcot-Marie-Tooth 1A: characteristics of a new population. J Neurol 252:972\u2013979","journal-title":"J Neurol"},{"key":"580_CR43","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/j.otsr.2017.04.019","volume":"104","author":"P Mary","year":"2018","unstructured":"Mary P, Servais L, Vialle R (2018) Neuromuscular diseases: diagnosis and management. Orthop Traumatol Surg Res 104:S89\u2013s95","journal-title":"Orthop Traumatol Surg Res"},{"key":"580_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2017.05.018","volume":"122","author":"ERB McCabe","year":"2017","unstructured":"McCabe ERB (2017) Modifier genes: moving from pathogenesis to therapy. Mol Genet Metab 122:1\u20133","journal-title":"Mol Genet Metab"},{"key":"580_CR45","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","volume":"378","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Darras BT, Chiriboga CA, Day JW, Campbell C, Connolly AM, Iannaccone ST, Kirschner J, Kuntz NL, Saito K, Shieh PB, Tulinius M, Mazzone ES, Montes J, Bishop KM, Yang Q, Foster R, Gheuens S, Bennett CF, Farwell W, Schneider E, De Vivo DC, Finkel RS (2018) Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med 378:625\u2013635","journal-title":"N Engl J Med"},{"key":"580_CR46","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1093\/hmg\/ddx180","volume":"26","author":"KJ Meyer","year":"2017","unstructured":"Meyer KJ, Anderson MG (2017) Genetic modifiers as relevant biological variables of eye disorders. Hum Mol Genet 26:R58\u2013r67","journal-title":"Hum Mol Genet"},{"key":"580_CR47","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1016\/j.celrep.2017.03.009","volume":"18","author":"KH Morelli","year":"2017","unstructured":"Morelli KH, Seburn KL, Schroeder DG, Spaulding EL, Dionne LA, Cox GA, Burgess RW (2017) Severity of demyelinating and axonal neuropathy mouse models is modified by genes affecting structure and function of peripheral nodes. Cell Rep 18:3178\u20133191","journal-title":"Cell Rep"},{"key":"580_CR48","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1055\/s-0036-1586263","volume":"36","author":"BM Morrison","year":"2016","unstructured":"Morrison BM (2016) Neuromuscular diseases. Semin Neurol 36:409\u2013418","journal-title":"Semin Neurol"},{"key":"580_CR49","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/WCO.0000000000000371","volume":"29","author":"V Nigro","year":"2016","unstructured":"Nigro V, Savarese M (2016) Next-generation sequencing approaches for the diagnosis of skeletal muscle disorders. Curr Opin Neurol 29:621\u2013627","journal-title":"Curr Opin Neurol"},{"key":"580_CR50","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.1155085","volume":"320","author":"GE Oprea","year":"2008","unstructured":"Oprea GE, Kr\u00f6ber S, McWhorter ML, Rossoll W, M\u00fcller S, Krawczak M, Bassell GJ, Beattie CE, Wirth B (2008) Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science 320:524\u2013527","journal-title":"Science"},{"key":"580_CR51","doi-asserted-by":"crossref","first-page":"175628561875450","DOI":"10.1177\/1756285618754501","volume":"11","author":"V Parente","year":"2018","unstructured":"Parente V, Corti S (2018) Advances in spinal muscular atrophy therapeutics. Ther Adv Neurol Disord 11:1756285618754501","journal-title":"Ther Adv Neurol Disord"},{"key":"580_CR52","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3389\/fgene.2020.00605","volume":"11","author":"C Passarelli","year":"2020","unstructured":"Passarelli C, Selvatici R, Carrieri A, Di Raimo FR, Falzarano MS, Fortunato F, Rossi R, Straub V, Bushby K, Reza M, Zharaieva I, D\u2019Amico A, Bertini E, Merlini L, Sabatelli P, Borgiani P, Novelli G, Messina S, Pane M, Mercuri E et al (2020) Tumor necrosis factor receptor SF10A (TNFRSF10A) SNPs correlate with corticosteroid response in Duchenne muscular dystrophy. Front Genet 11:605","journal-title":"Front Genet"},{"key":"580_CR53","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1212\/WNL.0b013e318207afeb","volume":"76","author":"E Pegoraro","year":"2011","unstructured":"Pegoraro E, Hoffman EP, Piva L, Gavassini BF, Cagnin S, Ermani M, Bello L, Soraru G, Pacchioni B, Bonifati MD, Lanfranchi G, Angelini C, Kesari A, Lee I, Gordish-Dressman H, Devaney JM, McDonald CM (2011) SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy. Neurology 76:219\u2013226","journal-title":"Neurology"},{"key":"580_CR54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/hmg\/ddu440","volume":"24","author":"D Pla-Mart\u00edn","year":"2015","unstructured":"Pla-Mart\u00edn D, Calpena E, Lupo V, M\u00e1rquez C, Rivas E, Sivera R, Sevilla T, Palau F, Espin\u00f3s C (2015) Junctophilin-1 is a modifier gene of GDAP1-related Charcot-Marie-Tooth disease. Hum Mol Genet 24:213\u2013229","journal-title":"Hum Mol Genet"},{"key":"580_CR55","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3389\/fnins.2019.01233","volume":"13","author":"L Poppe","year":"2019","unstructured":"Poppe L, Smolders S, Ru\u00e9 L, Timmers M, Lenaerts A, Storm A, Schoonaert L, de Boer A, Van Damme P, Van Den Bosch L, Robberecht W, Lemmens R (2019) Lowering EphA4 does not ameliorate disease in a mouse model for severe spinal muscular atrophy. Front Neurosci 13:1233","journal-title":"Front Neurosci"},{"key":"580_CR56","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2009.08.002","volume":"85","author":"TW Prior","year":"2009","unstructured":"Prior TW, Krainer AR, Hua Y, Swoboda KJ, Snyder PC, Bridgeman SJ, Burghes AH, Kissel JT (2009) A positive modifier of spinal muscular atrophy in the SMN2 gene. Am J Hum Genet 85:408\u2013413","journal-title":"Am J Hum Genet"},{"key":"580_CR57","doi-asserted-by":"publisher","unstructured":"Rahit K, Tarailo-Graovac M (2020) Genetic modifiers and rare Mendelian disease. Genes (Basel) 11(3):239. https:\/\/doi.org\/10.3390\/genes11030239","DOI":"10.3390\/genes11030239"},{"key":"580_CR58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pneurobio.2011.07.009","volume":"95","author":"G Riboldi","year":"2011","unstructured":"Riboldi G, Nizzardo M, Simone C, Falcone M, Bresolin N, Comi GP, Corti S (2011) ALS genetic modifiers that increase survival of SOD1 mice and are suitable for therapeutic development. Prog Neurobiol 95:133\u2013148","journal-title":"Prog Neurobiol"},{"key":"580_CR59","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ajhg.2017.01.005","volume":"100","author":"M Riessland","year":"2017","unstructured":"Riessland M, Kaczmarek A, Schneider S, Swoboda KJ, L\u00f6hr H, Bradler C, Grysko V, Dimitriadi M, Hosseinibarkooie S, Torres-Benito L, Peters M, Upadhyay A, Biglari N, Kr\u00f6ber S, H\u00f6lker I, Garbes L, Gilissen C, Hoischen A, N\u00fcrnberg G, N\u00fcrnberg P, Walter M, Rigo F, Bennett CF, Kye MJ, Hart AC, Hammerschmidt M, Kloppenburg P, Wirth B (2017) Neurocalcin delta suppression protects against spinal muscular atrophy in humans and across species by restoring impaired endocytosis. Am J Hum Genet 100:297\u2013315","journal-title":"Am J Hum Genet"},{"key":"580_CR60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajhg.2017.06.004","volume":"101","author":"JD Riordan","year":"2017","unstructured":"Riordan JD, Nadeau JH (2017) From peas to disease: modifier genes, network resilience, and the genetics of health. Am J Hum Genet 101:177\u2013191","journal-title":"Am J Hum Genet"},{"key":"580_CR61","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.cell.2014.10.050","volume":"159","author":"T Rolland","year":"2014","unstructured":"Rolland T, Ta\u015fan M, Charloteaux B, Pevzner SJ, Zhong Q, Sahni N, Yi S, Lemmens I, Fontanillo C, Mosca R, Kamburov A, Ghiassian SD, Yang X, Ghamsari L, Balcha D, Begg BE, Braun P, Brehme M, Broly MP, Carvunis AR, Convery-Zupan D, Corominas R, Coulombe-Huntington J, Dann E, Dreze M, Dricot A, Fan C, Franzosa E, Gebreab F, Gutierrez BJ, Hardy MF, Jin M, Kang S, Kiros R, Lin GN, Luck K, MacWilliams A, Menche J, Murray RR, Palagi A, Poulin MM, Rambout X, Rasla J, Reichert P, Romero V, Ruyssinck E, Sahalie JM, Scholz A, Shah AA, Sharma A, Shen Y, Spirohn K, Tam S, Tejeda AO, Trigg SA, Twizere JC, Vega K, Walsh J, Cusick ME, Xia Y, Barab\u00e1si AL, Iakoucheva LM, Aloy P, De Las Rivas J, Tavernier J, Calderwood MA, Hill DE, Hao T, Roth FP, Vidal M (2014) A proteome-scale map of the human interactome network. Cell 159:1212\u20131226","journal-title":"Cell"},{"key":"580_CR62","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40265-018-0868-8","volume":"78","author":"HK Shorrock","year":"2018","unstructured":"Shorrock HK, Gillingwater TH, Groen EJN (2018) Overview of current drugs and molecules in development for spinal muscular atrophy therapy. Drugs 78:293\u2013305","journal-title":"Drugs"},{"key":"580_CR63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10048-014-0426-9","volume":"16","author":"E Sinkiewicz-Darol","year":"2015","unstructured":"Sinkiewicz-Darol E, Lacerda AF, Kostera-Pruszczyk A, Potulska-Chromik A, Soko\u0142owska B, Kabzi\u0144ska D, Brunetti CR, Hausmanowa-Petrusewicz I, Kocha\u0144ski A (2015) The LITAF\/SIMPLE I92V sequence variant results in an earlier age of onset of CMT1A\/HNPP diseases. Neurogenetics 16:27\u201332","journal-title":"Neurogenetics"},{"key":"580_CR64","doi-asserted-by":"publisher","unstructured":"Spitali P, Zaharieva I, Bohringer S, Hiller M, Chaouch A, Roos A, Scotton C, Claustres M, Bello L, McDonald CM, Hoffman EP, Koeks Z, Eka Suchiman H, Cirak S, Scoto M, Reza M, t Hoen PAC, Niks EH, Tuffery-Giraud S, Lochm\u00fcller H, Ferlini A, Muntoni F, Aartsma-Rus A (2020) TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy. Eur J Hum Genet 28(6):815-825. https:\/\/doi.org\/10.1038\/s41431-019-0563-6","DOI":"10.1038\/s41431-019-0563-6"},{"key":"580_CR65","first-page":"26","volume":"38","author":"FG Sturtz","year":"1997","unstructured":"Sturtz FG, Latour P, Mocquard Y, Cruz S, Fenoll B, LeFur JM, Mabin D, Chazot G, Vandenberghe A (1997) Clinical and electrophysiological phenotype of a homozygously duplicated Charcot-Marie-Tooth (type 1A) disease. Eur Neurol 38:26\u201330","journal-title":"Eur Neurol"},{"key":"580_CR66","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1093\/hmg\/ddv139","volume":"24","author":"CT Su","year":"2015","unstructured":"Su CT, Huang JW, Chiang CK, Lawrence EC, Levine KL, Dabovic B, Jung C, Davis EC, Madan-Khetarpal S, Urban Z (2015) Latent transforming growth factor binding protein 4 regulates transforming growth factor beta receptor stability. Hum Mol Genet 24:4024\u20134036","journal-title":"Hum Mol Genet"},{"key":"580_CR67","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1073\/pnas.1324242111","volume":"111","author":"KA Swaggart","year":"2014","unstructured":"Swaggart KA, Demonbreun AR, Vo AH, Swanson KE, Kim EY, Fahrenbach JP, Holley-Cuthrell J, Eskin A, Chen Z, Squire K, Heydemann A, Palmer AA, Nelson SF, McNally EM (2014) Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair. Proc Natl Acad Sci U S A 111:6004\u20136009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"580_CR68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3233\/JND-190377","volume":"6","author":"F Tao","year":"2019","unstructured":"Tao F, Beecham GW, Rebelo AP, Blanton SH, Moran JJ, Lopez-Anido C, Svaren J, Abreu L, Rizzo D, Kirk CA, Wu X, Feely S, Verhamme C, Saporta MA, Herrmann DN, Day JW, Sumner CJ, Lloyd TE, Li J, Yum SW, Taroni F, Baas F, Choi BO, Pareyson D, Scherer SS, Reilly MM, Shy ME, Z\u00fcchner S (2019a) Modifier gene candidates in Charcot-Marie-Tooth disease type 1A: a case-only genome-wide association study. J Neuromuscul Dis 6:201\u2013211","journal-title":"J Neuromuscul Dis"},{"key":"580_CR69","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ana.25426","volume":"85","author":"F Tao","year":"2019","unstructured":"Tao F, Beecham GW, Rebelo AP, Svaren J, Blanton SH, Moran JJ, Lopez-Anido C, Morrow JM, Abreu L, Rizzo D, Kirk CA, Wu X, Feely S, Verhamme C, Saporta MA, Herrmann DN, Day JW, Sumner CJ, Lloyd TE, Li J, Yum SW, Taroni F, Baas F, Choi BO, Pareyson D, Scherer SS, Reilly MM, Shy ME, Z\u00fcchner S (2019b) Variation in SIPA1L2 is correlated with phenotype modification in Charcot-Marie-Tooth disease type 1A. Ann Neurol 85:316\u2013330","journal-title":"Ann Neurol"},{"key":"580_CR70","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.ajpath.2016.05.021","volume":"186","author":"PJ Thomas","year":"2016","unstructured":"Thomas PJ, Xu R, Martin PT (2016) B4GALNT2 (GALGT2) gene therapy reduces skeletal muscle pathology in the FKRP P448L mouse model of limb girdle muscular dystrophy 2I. Am J Pathol 186:2429\u20132448","journal-title":"Am J Pathol"},{"key":"580_CR71","first-page":"65","volume":"149","author":"N Ticozzi","year":"2011","unstructured":"Ticozzi N, Tiloca C, Morelli C, Colombrita C, Poletti B, Doretti A, Maderna L, Messina S, Ratti A, Silani V (2011) Genetics of familial amyotrophic lateral sclerosis. Arch Ital Biol 149:65\u201382","journal-title":"Arch Ital Biol"},{"key":"580_CR72","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1474-4422(13)70036-X","volume":"12","author":"MR Turner","year":"2013","unstructured":"Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, Ince PG, Lin C, Miller RG, Mitsumoto H, Nicholson G, Ravits J, Shaw PJ, Swash M, Talbot K, Traynor BJ, Van den Berg LH, Veldink JH, Vucic S, Kiernan MC (2013) Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol 12:310\u2013322","journal-title":"Lancet Neurol"},{"key":"580_CR73","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/nm.2901","volume":"18","author":"A Van Hoecke","year":"2012","unstructured":"Van Hoecke A, Schoonaert L, Lemmens R, Timmers M, Staats KA, Laird AS, Peeters E, Philips T, Goris A, Dubois B, Andersen PM, Al-Chalabi A, Thijs V, Turnley AM, van Vught PW, Veldink JH, Hardiman O, Van Den Bosch L, Gonzalez-Perez P, Van Damme P, Brown RH Jr, van den Berg LH, Robberecht W (2012) EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat Med 18:1418\u20131422","journal-title":"Nat Med"},{"key":"580_CR74","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1172-9-38","volume":"9","author":"BW van Paassen","year":"2014","unstructured":"van Paassen BW, van der Kooi AJ, van Spaendonck-Zwarts KY, Verhamme C, Baas F, de Visser M (2014) PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies. Orphanet J Rare Dis 9:38","journal-title":"Orphanet J Rare Dis"},{"key":"580_CR75","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1093\/brain\/awp251","volume":"132","author":"C Verhamme","year":"2009","unstructured":"Verhamme C, van Schaik IN, Koelman JH, de Haan RJ, de Visser M (2009) The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study. Brain 132:3252\u20133262","journal-title":"Brain"},{"key":"580_CR76","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/WCO.0000000000000240","volume":"28","author":"AH Vo","year":"2015","unstructured":"Vo AH, McNally EM (2015) Modifier genes and their effect on Duchenne muscular dystrophy. Curr Opin Neurol 28:528\u2013534","journal-title":"Curr Opin Neurol"},{"key":"580_CR77","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1212\/NXG.0000000000000386","volume":"6","author":"RI Wadman","year":"2020","unstructured":"Wadman RI, Jansen MD, Curial CAD, Groen EJN, Stam M, Wijngaarde CA, Medic J, Sodaar P, van Eijk KR, Huibers MMH, van Kuik J, Lemmink HH, van Rheenen W, Veldink JH, van den Berg LH, van der Pol WL (2020) Analysis of FUS, PFN2, TDP-43, and PLS3 as potential disease severity modifiers in spinal muscular atrophy. Neurol Genet 6:e386","journal-title":"Neurol Genet"},{"key":"580_CR78","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/WCO.0000000000000739","volume":"32","author":"MA Waldrop","year":"2019","unstructured":"Waldrop MA, Flanigan KM (2019) Update in Duchenne and Becker muscular dystrophy. Curr Opin Neurol 32:722\u2013727","journal-title":"Curr Opin Neurol"},{"key":"580_CR79","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/35066048","volume":"2","author":"DJ Weatherall","year":"2001","unstructured":"Weatherall DJ (2001) Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet 2:245\u2013255","journal-title":"Nat Rev Genet"},{"key":"580_CR80","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/hmg\/8.5.871","volume":"8","author":"T Weiler","year":"1999","unstructured":"Weiler T, Bashir R, Anderson LV, Davison K, Moss JA, Britton S, Nylen E, Keers S, Vafiadaki E, Greenberg CR, Bushby CR, Wrogemann K (1999) Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Hum Mol Genet 8:871\u2013877","journal-title":"Hum Mol Genet"},{"key":"580_CR81","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ana.25283","volume":"84","author":"RB Weiss","year":"2018","unstructured":"Weiss RB, Vieland VJ, Dunn DM, Kaminoh Y, Flanigan KM (2018) Long-range genomic regulators of THBS1 and LTBP4 modify disease severity in Duchenne muscular dystrophy. Ann Neurol 84:234\u2013245","journal-title":"Ann Neurol"},{"key":"580_CR82","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.gde.2013.03.003","volume":"23","author":"B Wirth","year":"2013","unstructured":"Wirth B, Garbes L, Riessland M (2013) How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic approaches. Curr Opin Genet Dev 23:330\u2013338","journal-title":"Curr Opin Genet Dev"},{"key":"580_CR83","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00415-018-8856-1","volume":"265","author":"J Witherick","year":"2018","unstructured":"Witherick J, Brady S (2018) Update on muscle disease. J Neurol 265:1717\u20131725","journal-title":"J Neurol"},{"key":"580_CR84","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.ajpath.2015.06.008","volume":"185","author":"R Xu","year":"2015","unstructured":"Xu R, Singhal N, Serinagaoglu Y, Chandrasekharan K, Joshi M, Bauer JA, Janssen PM, Martin PT (2015) Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice. Am J Pathol 185:2668\u20132684","journal-title":"Am J Pathol"},{"key":"580_CR85","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ymthe.2019.01.005","volume":"27","author":"R Xu","year":"2019","unstructured":"Xu R, Jia Y, Zygmunt DA, Martin PT (2019) rAAVrh74.MCK.GALGT2 protects against loss of hemodynamic function in the aging mdx mouse heart. Mol Ther 27:636\u2013649","journal-title":"Mol Ther"},{"key":"580_CR86","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1016\/j.neuroscience.2018.10.033","volume":"396","author":"KS Yanagi","year":"2019","unstructured":"Yanagi KS, Wu Z, Amaya J, Chapkis N, Duffy AM, Hajdarovic KH, Held A, Mathur AD, Russo K, Ryan VH, Steinert BL, Whitt JP, Fallon JR, Fawzi NL, Lipscombe D, Reenan RA, Wharton KA, Hart AC (2019) Meta-analysis of genetic modifiers reveals candidate dysregulated pathways in amyotrophic lateral sclerosis. Neuroscience 396:A3\u2013a20","journal-title":"Neuroscience"}],"container-title":["Journal of Applied Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13353-020-00580-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13353-020-00580-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13353-020-00580-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T00:33:19Z","timestamp":1631320399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13353-020-00580-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["580"],"URL":"https:\/\/doi.org\/10.1007\/s13353-020-00580-6","relation":{},"ISSN":["1234-1983","2190-3883"],"issn-type":[{"value":"1234-1983","type":"print"},{"value":"2190-3883","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"assertion":[{"value":"27 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}